Synovial sarcoma was originally coined early in the 20th century as some thought that the microscopic similarity of some tumors to synovium and its propensity to arise adjacent to joints indicated a synovial origin; however, the actual cells from which the tumor develops are unknown and not necessarily synovial.
Primary synovial sarcomas are most common in the soft tissue near the large joints of the arm and leg but have been documented in most human tissues and organs, including the brain, prostate and heart.
Synovial Sarcoma sarcoma occurs most commonly in the young, representing about 8% of all soft tissue sarcomas but about 15-20% of cases in adolescents and young adults. The peak of incidence is before the 30th birthday and males are affected more often than females (ratio around 1.2:1).
Synovial sarcoma usually presents with an otherwise asymptomatic swelling or mass, although general symptoms related to malignicies can be reported such as fatigue.
Treatment usually involves:
- Surgery, to remove the tumor and a safety margin of healthy tissue. This is the mainstay of synovial sarcoma treatment and is curative in approximately 20-70% of patients,depending on the particular study being quoted.
- Conventional chemotherapy, (for example, doxorubicin hydrochloride and ifosfamide), to reduce the number of remaining microscopic cancer cells. The benefit of chemotherapy in synovial sarcoma to overall survival remains unclear, although a recent study has shown that survival of patients with advanced, poorly differentiated disease marginally improves with doxorubicin/ifosfamide treatment.
- Radiotherapy to reduce the chance of local recurrence. The benefit of radiotherapy in this disease is less clear than for chemotherapy.
The word synovial, comes from synovium, meaning the tissues lining joints. Since these tumors are of a type that when pieces are looked at under the microscope, and arise near or around joints, it was assumed they were “synovial” sarcomas. The current view is that they have nothing to do with synovium. Old knowledge replaced by new. Eventually there will be a new classification system for sarcomas.